1. Home
  2. AORT vs LMAT Comparison

AORT vs LMAT Comparison

Compare AORT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AORT
  • LMAT
  • Stock Information
  • Founded
  • AORT 1984
  • LMAT 1983
  • Country
  • AORT United States
  • LMAT United States
  • Employees
  • AORT N/A
  • LMAT N/A
  • Industry
  • AORT Medical/Dental Instruments
  • LMAT Medical/Dental Instruments
  • Sector
  • AORT Health Care
  • LMAT Health Care
  • Exchange
  • AORT Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • AORT 2.1B
  • LMAT 1.9B
  • IPO Year
  • AORT 1993
  • LMAT 2006
  • Fundamental
  • Price
  • AORT $39.96
  • LMAT $92.11
  • Analyst Decision
  • AORT Strong Buy
  • LMAT Buy
  • Analyst Count
  • AORT 6
  • LMAT 6
  • Target Price
  • AORT $40.63
  • LMAT $99.67
  • AVG Volume (30 Days)
  • AORT 407.7K
  • LMAT 172.9K
  • Earning Date
  • AORT 11-06-2025
  • LMAT 10-30-2025
  • Dividend Yield
  • AORT N/A
  • LMAT 0.87%
  • EPS Growth
  • AORT N/A
  • LMAT 22.69
  • EPS
  • AORT N/A
  • LMAT 2.05
  • Revenue
  • AORT $405,037,000.00
  • LMAT $234,639,000.00
  • Revenue This Year
  • AORT $14.99
  • LMAT $16.32
  • Revenue Next Year
  • AORT $10.80
  • LMAT $8.62
  • P/E Ratio
  • AORT N/A
  • LMAT $45.02
  • Revenue Growth
  • AORT 7.44
  • LMAT 14.11
  • 52 Week Low
  • AORT $21.97
  • LMAT $71.42
  • 52 Week High
  • AORT $45.07
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • AORT 45.52
  • LMAT 45.86
  • Support Level
  • AORT $39.27
  • LMAT $91.24
  • Resistance Level
  • AORT $44.47
  • LMAT $98.93
  • Average True Range (ATR)
  • AORT 1.23
  • LMAT 2.58
  • MACD
  • AORT -0.85
  • LMAT -0.88
  • Stochastic Oscillator
  • AORT 13.27
  • LMAT 16.01

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: